SCHEMBL7243458

SCHEMBL7243458

c1ccc(CC2CCCCN2CCCCOc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 2/20 0.53
SIGMAR1 Q99720 2/20 0.53
HRH3 Q9Y5N1 3/20 0.47
SLC2A1 P11166 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ADRA1D P25100 3/20 0.46
ADRA1A P35348 3/20 0.46
ADRA1B P35368 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7245268 0.99 TMEM97 (0.52) TMEM97SIGMAR1HRH3SLC2A1NPC1
Bromide SCHEMBL5888803 0.99 TMEM97 (0.52) TMEM97SIGMAR1HRH3SLC2A1NPC1
Bromide SCHEMBL7251227 0.97 TMEM97 (0.51) TMEM97SIGMAR1HRH3SLC2A1NPC1
SCHEMBL7250983 0.96 TMEM97 (0.58) TMEM97SIGMAR1HRH3NPC1RAB9A
Bromide SCHEMBL5888830 0.95 TMEM97 (0.56) TMEM97SIGMAR1HRH3NPC1RAB9A
SCHEMBL7242510 0.93 KDM4E (0.57) TMEM97SIGMAR1HRH3NPC1RAB9A
SCHEMBL5888840 0.92 TMEM97 (0.57) TMEM97SIGMAR1
Bromide SCHEMBL7248969 0.91 TMEM97 (0.56) TMEM97SIGMAR1NPC1RAB9AHPGD
Hydrochloric Acid SCHEMBL7250296 0.91 ESR1 (0.51) TMEM97SIGMAR1HRH3NPC1RAB9A
SCHEMBL7250692 0.89 KDM4E (0.46) TMEM97SIGMAR1HRH3KDM4EADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534525-B1 Method of using 2- substituted piperidine analogs as selectively active antagonist of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, WARNER-LAMBERT & COMPANY 2003-03-18 US disclosed
US-6124317-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
WO-1997023215-A1 2-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed